Monash IVF Group Overview

  • Status
  • Public

  • Employees
  • 547

Employees

  • Stock Symbol
  • MVF

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $0.51
  • (As of Tuesday Closing)

Monash IVF Group General Information

Description

Monash IVF Group Ltd is a provider of fertility services and a driving force in the development of Assisted Reproductive Technologies (ART) and tertiary-level prenatal diagnostics, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates through two main segments: Australia IVF and Ultrasound, which provides Assisted Reproductive Services, Ultrasound and other related services, and other related services. Its business includes KL Fertility, Monash IVF, Monash IVF KPJ Johor, Monash Ultrasound for Women and Repromed, among others. The majority of revenue is generated from the Australia IVF and Ultrasound segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Level 1
  • 510 Church Street
  • Cremorne, Victoria 3121
  • Australia
Primary Industry
Clinics/Outpatient Services
Other Industries
Laboratory Services (Healthcare)
Stock Exchange
ASX
Corporate Office
  • Level 1
  • 510 Church Street
  • Cremorne, Victoria 3121
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Monash IVF Group Stock Performance

As of 17-Nov-2026, Monash IVF Group’s stock price is $0.51. Its current market cap is $199M with 390M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.51 $0.49 $0.38 - $0.60 $199M 390M 745K $0.01

Monash IVF Group Financials Summary

As of 30-Jun-2026, Monash IVF Group has a trailing 12-month revenue of $183M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 327,633 327,633 281,690 412,902
Revenue 182,539 182,539 175,935 167,085
EBITDA 29,475 29,475 42,335 8,673
Net Income 5,030 5,030 16,181 (4,277)
Total Assets 352,596 352,596 321,766 339,861
Total Debt 137,375 137,375 117,594 90,481
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Monash IVF Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Monash IVF Group‘s full profile, request access.

Request a free trial

Monash IVF Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Monash IVF Group Ltd is a provider of fertility services and a driving force in the development of Assisted Reproductive
Clinics/Outpatient Services
Cremorne, Australia
547 As of 2026

Greenwich, Australia
 

Greenwich, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Monash IVF Group Competitors (3)

One of Monash IVF Group’s 3 competitors is Virtus Health, a Private Equity-Backed company based in Greenwich, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Virtus Health Private Equity-Backed Greenwich, Australia
IVF Australia Private Equity-Backed Greenwich, Australia
Melbourne IVF Private Equity-Backed East Melbourne, Australia
You’re viewing 3 of 3 competitors. Get the full list »

Monash IVF Group Patents

Monash IVF Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019902204-A0 Methods of predicting endometrial receptivity Inactive 25-Jun-2019
AU-2020302958-A1 Methods of predicting endometrial receptivity Inactive 25-Jun-2019
CA-3145010-A1 Methods of predicting endometrial receptivity Pending 25-Jun-2019
EP-3990663-A1 Methods of predicting endometrial receptivity Inactive 25-Jun-2019
EP-3990663-A4 Methods of predicting endometrial receptivity Inactive 25-Jun-2019 C12Q1/6876
To view Monash IVF Group’s complete patent history, request access »

Monash IVF Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Monash IVF Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Monash IVF Group‘s full profile, request access.

Request a free trial

Monash IVF Group Investments & Acquisitions (9)

Monash IVF Group’s most recent deal was a Merger/Acquisition with Fertility North for . The deal was made on 04-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fertility North 04-Mar-2024 Merger/Acquisition Clinics/Outpatient Services
Symex Labs 01-Jan-2024 Early Stage VC Monitoring Equipment
PIVET Medical Centre 27-May-2023 Merger/Acquisition Clinics/Outpatient Services
ART Associates Queensland #2 01-Jul-2022 Merger/Acquisition Other Healthcare Services
Fertility Solutions 10-Jul-2019 Merger/Acquisition Clinics/Outpatient Services
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Monash IVF Group ESG

Risk Overview

Risk Rating

Updated March, 31, 2026

23.75 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Healthcare

Industry

of 614

Rank

Percentile

Medical Services

Subindustry

of 100

Rank

Percentile

To view Monash IVF Group’s complete esg history, request access »

Monash IVF Group Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Fertility Solutions Buderim, Australia 2007
Fertility North Joondalup, Australia 2002
Sydney Ultrasound for Women Bella Vista, Australia 1986
Kl Fertility Centre Kuala Lumpur, Malaysia

Monash IVF Group FAQs

  • Where is Monash IVF Group headquartered?

    Monash IVF Group is headquartered in Cremorne, Australia.

  • What is the size of Monash IVF Group?

    Monash IVF Group has 547 total employees.

  • What industry is Monash IVF Group in?

    Monash IVF Group’s primary industry is Clinics/Outpatient Services.

  • Is Monash IVF Group a private or public company?

    Monash IVF Group is a Public company.

  • What is Monash IVF Group’s stock symbol?

    The ticker symbol for Monash IVF Group is MVF.

  • What is the current stock price of Monash IVF Group?

    As of 17-Nov-2026 the stock price of Monash IVF Group is $0.51.

  • What is the current market cap of Monash IVF Group?

    The current market capitalization of Monash IVF Group is $199M.

  • What is Monash IVF Group’s current revenue?

    The trailing twelve month revenue for Monash IVF Group is $183M.

  • Who are Monash IVF Group’s competitors?

    Virtus Health, IVF Australia, and Melbourne IVF are competitors of Monash IVF Group.

  • What is Monash IVF Group’s annual earnings per share (EPS)?

    Monash IVF Group’s EPS for 12 months was $0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process